Literature DB >> 18806824

Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence.

C Leikam1, A Hufnagel, M Schartl, S Meierjohann.   

Abstract

Contrary to malignant melanoma, nevi are a benign form of melanocytic hyperproliferation. They are frequently observed as precursor lesions of melanoma, but they also feature biochemical markers of senescence. In particular, evidence for oncogene-induced melanocyte senescence as natural means to prevent tumorigenesis has been obtained in nevi with mutated B-Raf(V600E). Here, we demonstrate that strong oncogenic growth factor receptor signalling drives melanocytes into senescence, whereas weaker signals keep them in the proliferative state. Activation of oncogene-induced senescence also produces multinucleated giant cells, a long known histological feature of nevus cells. The protein levels of the senescence mediators, p53 and pRB, and their upstream activators do not correlate with senescence. However, strong oncogene signalling leads to pronounced reactive oxygen stress, and scavenging of reactive oxygen species (ROS) efficiently prevents the formation of multinucleated cells and senescence. Similarly, expression of oncogenic N-RAS results in ROS generation, DNA damage and the same multinuclear senescent phenotype. Hence, we identified oncogenic signalling-dependent ROS production as critical mediator of the melanocytic multinuclear phenotype and senescence, both of them being hallmarks of human nevus cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806824     DOI: 10.1038/onc.2008.323

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

Review 1.  Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place.

Authors:  Panagiotis Kotsantis; Eva Petermann; Simon J Boulton
Journal:  Cancer Discov       Date:  2018-04-13       Impact factor: 39.397

2.  A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF.

Authors:  Jiyeon Choi; Mai Xu; Matthew M Makowski; Tongwu Zhang; Matthew H Law; Michael A Kovacs; Anton Granzhan; Wendy J Kim; Hemang Parikh; Michael Gartside; Jeffrey M Trent; Marie-Paule Teulade-Fichou; Mark M Iles; Julia A Newton-Bishop; D Timothy Bishop; Stuart MacGregor; Nicholas K Hayward; Michiel Vermeulen; Kevin M Brown
Journal:  Nat Genet       Date:  2017-07-31       Impact factor: 38.330

3.  A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines.

Authors:  Craig Carson; Bernard Omolo; Haitao Chu; Yingchun Zhou; Maria J Sambade; Eldon C Peters; Patrick Tompkins; Dennis A Simpson; Nancy E Thomas; Cheng Fan; Alain Sarasin; Philippe Dessen; Janiel M Shields; Joseph G Ibrahim; William K Kaufmann
Journal:  Pigment Cell Melanoma Res       Date:  2012-06-01       Impact factor: 4.693

4.  Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence.

Authors:  Peter L J de Keizer; Leisl M Packer; Anna A Szypowska; Paulien E Riedl-Polderman; Niels J F van den Broek; Alain de Bruin; Tobias B Dansen; Richard Marais; Arjan B Brenkman; Boudewijn M T Burgering
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

5.  Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.

Authors:  Aditya Parekh; Subhayan Das; Sheetal Parida; Chandan Kanta Das; Debabrata Dutta; Sanjaya K Mallick; Pei-Hsun Wu; B N Prashanth Kumar; Rashmi Bharti; Goutam Dey; Kacoli Banerjee; Shashi Rajput; Deblina Bharadwaj; Ipsita Pal; Kaushik Kumar Dey; Yetirajam Rajesh; Bikash Chandra Jena; Angana Biswas; Payel Banik; Anjan K Pradhan; Swadesh K Das; Amit Kumar Das; Santanu Dhara; Paul B Fisher; Denis Wirtz; Gordon B Mills; Mahitosh Mandal
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

6.  Nano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells.

Authors:  Kunishige Onuma; Yu Sato; Satomi Ogawara; Nobuyuki Shirasawa; Masanobu Kobayashi; Jun Yoshitake; Tetsuhiko Yoshimura; Masaaki Iigo; Junichi Fujii; Futoshi Okada
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

7.  Transcriptional control analyses of the Xiphophorus melanoma oncogene.

Authors:  Janine Regneri; Jean-Nicolas Volff; Manfred Schartl
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-09-05       Impact factor: 3.228

8.  The Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes.

Authors:  Wei Zhao; Joseph Mazar; Bongyong Lee; Junko Sawada; Jian-Liang Li; John Shelley; Subramaniam Govindarajan; Dwight Towler; John S Mattick; Masanobu Komatsu; Marcel E Dinger; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2016-01-29       Impact factor: 8.551

9.  Lineage-specific co-evolution of the Egf receptor/ligand signaling system.

Authors:  Juliette A G C Laisney; Ingo Braasch; Ronald B Walter; Svenja Meierjohann; Manfred Schartl
Journal:  BMC Evol Biol       Date:  2010-01-27       Impact factor: 3.260

10.  The combination of mitogenic stimulation and DNA damage induces chondrocyte senescence.

Authors:  M E Copp; M C Flanders; R Gagliardi; J M Gilbertie; G A Sessions; S Chubinskaya; R F Loeser; L V Schnabel; B O Diekman
Journal:  Osteoarthritis Cartilage       Date:  2020-11-20       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.